Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
about
Systemic delivery to central nervous system by engineered PLGA nanoparticlesNanoparticles for imaging and treating brain cancerQuantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution.Functionalized nano-graphene oxide particles for targeted fluorescence imaging and photothermy of glioma U251 cellsEvolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.Development of docetaxel nanocrystals surface modified with transferrin for tumor targetingNanotechnology applications for glioblastoma.Handling of iron oxide and silver nanoparticles by astrocytes.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsNanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation.The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis.Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.A simple and robust method for pre-wetting poly (lactic-co-glycolic) acid microspheres.Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery.Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier.Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.Applications of Nanoparticles for MRI Cancer Diagnosis and TherapyPLGA-Based Nanoparticles in Cancer Treatment
P2860
Q26751294-17CFA115-1C1F-4FD7-800F-55D477011036Q28394053-B38DDA1F-9359-425E-9936-0653B45E2013Q34759412-35D3CD4B-5F84-4C13-90C9-CF804FE49D7AQ35619914-AA6482D0-8607-4AE2-B782-6BA894E4ED4EQ36010332-002CF5A5-B7B6-462C-A2B8-D8572E59A378Q36235151-8ECA2CB6-8109-47B7-96F0-1C18EAA8D5D5Q38022853-3EA92F3B-46F2-476B-8CDF-9807E30538FEQ38066031-9755941A-5D1E-47E3-B1B9-3690AB3F6EF0Q38086377-28878267-AC1A-4059-A88A-30918F4909F5Q38130176-94440B1C-D264-4C6D-9742-E6CF3D51655BQ38191445-C3F36CB3-C929-40A4-93A4-D1A3CB5FDE84Q38235410-1A4ADE57-65BB-432F-959B-7FC5816856E9Q38275050-3B96722F-7737-4F4B-B098-5652EC0F3F54Q38619134-0F62C1DF-67F1-4A58-8322-CA1CC0A269FEQ38746950-DF090941-8D9A-4EAF-96CF-2443A9EAAAA0Q38750666-299FA293-68E5-46B0-BDF1-B9FDC7F7A805Q38813247-55719D6B-418F-4654-ABCC-CF386CF829D9Q38826277-235EE233-9787-4183-AAA8-35B87F5065FDQ38859668-3B245DC4-53FC-4294-98CD-7154EB2B7740Q38998571-EC6DEC12-5064-4FF3-9C02-7F23F4AD85B6Q39043216-C636F7DE-9B5C-4916-8DE2-DE459A634330Q41283476-3B183366-AE0C-4F8C-B343-6CBD1D5FD9A7Q42131372-26E5FA0E-5E6B-45C0-AAB0-D1E017903B00Q42688132-E1200C2F-846B-426B-ADAB-D2838469CB81Q47243623-44A16231-77AB-4B66-8379-9D4DE8E421BEQ47996128-57F35D2C-069A-4120-BBC8-A1488E0CADE1Q48025703-B0748603-7441-47F1-B628-83256D369E34Q59016514-D2AC5D0D-446C-45D5-ADE9-A2E36742585AQ59137460-C0CDA9AE-8767-43A9-9681-25353C229DF1
P2860
Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@en
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@nl
type
label
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@en
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@nl
prefLabel
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@en
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@nl
P2093
P2860
P1476
Transferrin adsorption onto PL ...... ulation to brain cancer cells.
@en
P2093
Archibald Paillard
Catherine Passirani
Emmanuel Garcion
Jean-Pierre Benoit
Jiang Chang
P2860
P304
P356
10.1007/S11095-011-0624-1
P577
2011-12-14T00:00:00Z